Description

Salmerix (Salmeterol, Fluticasone) Powder for Inhalation

Ingredients

• Each dose contains 50 mcg of salmeterol and 250 mcg of fluticasone.

Dosage

• The usual dose is 1 inhalation twice daily, approximately 12 hours apart.

Indications

• Salmerix is indicated for the maintenance treatment of asthma in patients aged 4 years and older.

Contraindications

• Do not use Salmerix for the relief of acute bronchospasm.

Directions

• It is important to rinse your mouth with water after each use to prevent oral thrush.

Scientific Evidence

Salmerix combines salmeterol and fluticasone to provide a dual-action approach in managing asthma. Salmeterol relaxes airway muscles, while fluticasone reduces inflammation. Clinical trials show improved lung function and reduced asthma symptoms compared to monotherapy.

Additional Information

• Use Salmerix regularly as prescribed, even without symptoms. Not for acute attacks; carry a rescue inhaler.

Pharmacological Effects

• Combination provides bronchodilation and anti-inflammatory effects, targeting asthma pathophysiology.
• Salmeterol acts on beta-2 adrenergic receptors for bronchodilation, while fluticasone reduces inflammation, mucus, and swelling.

Clinical Trials

• Studies confirm Salmerix efficacy and safety in asthma management, with fewer exacerbations and improved lung function compared to standard treatments.